FDA Warns Marijuana Company Curaleaf for Making CBD Health Claims - NBC Southern California
National & International News
The day’s top national and international news

FDA Warns Marijuana Company Curaleaf for Making CBD Health Claims

The Food and Drug Administration has announced it warned Curaleaf Inc., of Wakefield, for illegally selling unapproved products

    processing...

    NEWSLETTERS

    BBJ: FDA Issues Warning to Curaleaf Over CBD Products

    Reporter Jessica Bartlett joins necn to discuss her story, " FDA issues warning to Wakefield-based Curaleaf over CBD products."

    (Published Tuesday, July 23, 2019)

    U.S. regulators warned a leading marijuana company for making unproven health claims about CBD, the trendy ingredient that's turning up in lotions, foods and pet treats.

    The Food and Drug Administration announced Tuesday it warned Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products. Curaleaf's claims could lead people to delay medical care for serious conditions like cancer, the agency said.

    "Consumers should beware of purchasing or using any such products," said Acting FDA Commissioner Ned Sharpless in a statement.

    The FDA has issued similar warning letters to smaller businesses, but this is the first since the agency began studying how it regulates CBD. The agency plans to report in the fall on its regulatory approach after holding a public hearing and receiving nearly 4,500 comments.

    Death Toll, Damages Climb From Typhoon Hagibis

    [NATL] Death Toll, Damages Climb From Typhoon Hagibis

    The death toll from Typhoon Hagibis climbed to 53 on Tuesday, days after it tore through Japan and left hundreds of thousands of homes wrecked, flooded or out of power. Hagibis caused more than 200 rivers to overflow when it hit the island nation on Saturday.

    (Published Tuesday, Oct. 15, 2019)

    The agency is exploring "potential regulatory pathways" for some CBD products to be lawfully marketed, Sharpless said.

    Curaleaf, which operates in 12 states, said it will work with the FDA to resolve the issues mentioned in the warning letter. The company's shares fell more than 7% on the news, and some other cannabis stocks lost ground.

    "The company is fully committed to complying with FDA requirements for all of the products that it markets," Curaleaf said in a statement.

    CVS Health, which started carrying CBD skin products in some states this year, plans to remove Curaleaf from its shelves following the FDA's warning, said CVS spokesman Mike DeAngelis in an email. The drugstore chain has been selling Curaleaf CBD lotion and skin patches. CVS does not sell any CBD supplements or foods, DeAngelis said.

    CBD is a compound found in marijuana that doesn't cause a high. Its skyrocketing popularity has attracted mainstream retailers despite little evidence of its health claims.

    Curaleaf's website and social media accounts show the company is illegally selling unapproved new drugs, the FDA said, specifically its CBD lotion, a pain-relief patch, several tinctures and disposable vape pens.

    Quadruple Murder Suspect Brings Body to Police Station

    [NATL] Quadruple Murder Suspect Brings Body to Police Station

    A Roseville, California, man is in custody after he turned himself in to police in connection to a quadruple homicide.  The body of one of his victims was in the car he drove to the police station in Mount Shasta, more than 200 miles away from the original Roseville crime scene.

    (Published Tuesday, Oct. 15, 2019)

    The company's Bido CBD for Pets products are unapproved new animal drugs, the FDA said.

    The FDA cited claims the company made for CBD's effectiveness in treating chronic pain, anxiety, attention deficit disorder, Alzheimer's disease, Parkinson's disease, cancer and opioid withdrawal.

    Curaleaf said all its CBD products come from hemp, a version of the cannabis plant that is low in THC, the part of cannabis that gives pot its high.

    Hemp gained new status as an agricultural crop late last year when President Donald Trump signed the farm bill.

    The CBD industry hoped the legislation would allow broad sales of the ingredient.

    But the FDA still regulates pharmaceutical products. Since CBD is the active ingredient of GW Pharmaceuticals' Epidiolex, approved by the FDA last year, the agency has said it can't be added to food or marketed to treat health conditions without going through the FDA's established processes.

    Taco Bell Recalls 2.3 Million Pounds of Ground Beef

    [NATL] Taco Bell Recalls 2.3 Million Pounds of Ground Beef

    Taco Bell has voluntarily recalled 2.3 million pounds of seasoned ground beef that originated at Kenosha Beef International in Columbus, Ohio, because of possible contamination with metal shavings. The USDA says there have been no confirmed reports of any adverse reaction.

    (Published Tuesday, Oct. 15, 2019)